Bay Area's second IPO of the year hits top of targets, raises $238M
February 12, 2020 at 20:33 PM EST
The Redwood City oncology biotech agreed to sell 14 million shares at $17 apiece, giving it an initial market cap of about $967 million going into its Wall Street debut.
